QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report “FDA-cleared Wearable Pulse Oximeter- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global FDA-cleared Wearable Pulse Oximeter market, including market size, share, demand, industry development status, and forecasts for the next few years.
The global market for FDA-cleared Wearable Pulse Oximeter was estimated to be worth US$ 1174 million in 2025 and is projected to reach US$ 1765 million, growing at a CAGR of 6.0% from 2026 to 2032.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/5546929/fda-cleared-wearable-pulse-oximeter
1. FDA-cleared Wearable Pulse Oximeter Product Introduction
A FDA-cleared wearable pulse oximeter represents a specific regulatory and technical designation. Unlike general wellness devices or those with only CE marking, it has undergone the U.S. Food and Drug Administration’s 510(k) premarket notification process or De Novo classification. This clearance is contingent upon the device demonstrating substantial equivalence to a legally marketed predicate device in terms of its intended use and technological characteristics, or establishing safety and effectiveness for a new type of device. The core substantiation involves rigorous validation of its measurement accuracy (SpO2 and pulse rate) under both controlled laboratory conditions and anticipated real-world use scenarios, including motion artifacts and low perfusion states. It must meet predefined performance standards (e.g., ISO 80601-2-61) and provide sufficient clinical data to support its claims. The clearance mandates adherence to Quality System Regulation (QSR), ensuring design controls, manufacturing consistency, and post-market surveillance. The outcome is a device whose functional reliability and safety profile are formally recognized by the FDA for use in measuring physiological oxygen saturation and heart rate. This establishes a higher threshold of verifiable performance and risk management compared to non-cleared wearables, translating to outputs that clinicians and users can rely upon for observational, spot-check, or ongoing monitoring outside clinical settings, with the understanding that it is not typically intended for diagnosis or life-critical alarms without further validation.
2. Leading Manufacturer in the industry
1) Zacurate
Zacurate is a company focused on the research and development of personal health monitoring devices and the manufacturing of consumer medical electronic products, with its core business centered on the design, production, and quality control of fingertip physiological monitoring instruments, placing particular emphasis on product reliability, user accessibility, and an easy-to-use experience. During product development, the company prioritizes functional stability and measurement consistency as core objectives, and ensures that end products meet the needs of household health monitoring, sports scenarios, and general non-clinical environments through standardized production processes, component reliability validation, and multiple rounds of performance testing. At the same time, Zacurate places importance on consumer education and usability design, highlighting intuitive operation, simplicity, and rapid feedback in product structure, operating logic, and information display, enabling non-professional users to easily complete physiological parameter monitoring; the company also provides accessory solutions, after-sales support, and technical consultation services, forming a comprehensive product and service system centered on personal health monitoring devices. Focusing on its pulse oximeter product line, Zacurate takes fingertip pulse oximeters as the core technological platform and continues structural optimization and algorithm improvements in the monitoring of blood oxygen saturation (SpO₂) and pulse rate, with an emphasis on enhancing device adaptability and reading stability across different finger sizes, ambient light conditions, and everyday usage scenarios. Its products generally adopt a spring-clip fingertip design and non-invasive optical measurement technology, combined with a large digital display interface that clearly presents key indicators such as blood oxygen saturation, pulse rate, and pulse strength, covering a product portfolio that ranges from Over-the-counter Pulse Oximeters for everyday self-monitoring to prescription-grade models intended for higher-precision and clinically relevant monitoring needs. In this product field, Zacurate places strong emphasis on material safety and wearing comfort, including the use of hypoallergenic silicone finger chambers, durable housings, and portable structural designs, while also providing accessories such as protective cases, lanyards, and batteries, ensuring that the products deliver both functional stability and long-term user comfort, thereby establishing distinctive product advantages and brand positioning in the consumer pulse oximeter market. The Over-the-counter version Zacurate 500DL Pro Series Fingertip Pulse Oximeter is a portable, non-invasive fingertip pulse oximeter designed for everyday health monitoring, sports, and aviation use, and is intended for independent use by non-medical professionals. The device features a spring-loaded fingertip-clip design for easy operation: users insert a finger into the sensor chamber and press the power button, after which measurements are obtained in approximately 10 seconds and clearly displayed on a large LED screen, including blood oxygen saturation (SpO₂), pulse rate (Pulse Rate), and a bar-graph indicator of pulse strength. It supports a display range of up to 100% SpO₂, delivers stable and reliable accuracy under typical usage conditions (approximately ±2%), and uses a high-quality, hypoallergenic silicone finger chamber that provides comfortable wear and accommodates a variety of finger sizes, while also being supplied with batteries, a silicone protective cover, and a lanyard for convenient portability. This model is designed in accordance with relevant CE and FDA standards for general health monitoring, sports performance tracking, and outdoor activities, but is not intended for medical diagnosis; in comparison, the prescription version Zacurate 500DL-M Medical Prescription Pulse Oximeter provides the same functional capability to measure blood oxygen saturation (SpO₂) and pulse rate, but its design and intended use are oriented toward medical and clinical environments such as hospitals, clinics, long-term care facilities, and home healthcare settings, and purchase and use typically require a prescription from a qualified healthcare professional. This version aligns more closely with medical-device-grade expectations in terms of accuracy, calibration, and regulatory compliance, making it suitable for users who require clinically referenced or medically guided monitoring, while the OTC version is more appropriate for general self-monitoring and fitness or activity-related tracking needs.
2) Nonin Medical
Nonin Medical is a company dedicated to the research, development, and manufacture of noninvasive patient monitoring technologies, with its core business centered on professional-grade sensing, signal processing, and device engineering for clinical and personal health applications across hospital, emergency, home-care, aviation, and research environments. The company focuses on designing hardware and software that deliver consistent performance across diverse patient populations and real-world conditions, emphasizing accuracy, usability, and durability in demanding care settings. Through integrated product development, regulatory compliance processes, and long-term collaboration with clinicians, system integrators, and medical device partners, Nonin Medical positions its solutions as reliable components within broader care and monitoring ecosystems, supporting both standalone device use and connectivity with digital health platforms, remote monitoring programs, and clinical workflow systems.
Within its pulse oximetry portfolio, Nonin Medical develops a wide range of wearable, fingertip, handheld, and sensor-based pulse oximeters built around proprietary optical technology and signal algorithms designed to provide stable oxygen saturation (SpO₂) and pulse rate measurements across variations in skin tone, perfusion levels, motion, and environmental lighting. The company’s devices feature ergonomic sensor designs, high-visibility displays, and guided feedback mechanisms that support proper placement and measurement quality, while selected models incorporate wireless communication capabilities for data transmission, trending, and patient monitoring integration. Nonin Medical offers both Over-the-counter Pulse Oximeters intended for personal and home-use self-monitoring, as well as prescription-grade clinical pulse oximeters designed for use by healthcare professionals in diagnostic and care-management contexts, creating a product landscape that spans consumer wellness, remote patient monitoring, and professional medical environments.
The Nonin TruO2 OTC Wireless Fingertip Pulse Oximeter is an FDA-cleared wearable pulse oximeter designed to deliver reliable, medical-grade monitoring of blood oxygen saturation (SpO₂) and pulse rate for a broad range of users and conditions. Built on the same advanced pulse oximetry technology Nonin has developed for clinical, patient, and military applications, the TruO2 OTC provides accurate SpO₂ and pulse rate measurements across all skin tones and perfusion levels, addressing known disparities in pulse oximeter accuracy. Its intuitive fingertip design and easy-to-read digital display allow users to simply insert a finger and obtain fast readings, with built-in feedback systems that help ensure proper placement and signal quality. As an Over-the-counter Pulse Oximeter, this device is cleared by the U.S. Food and Drug Administration for home and personal health monitoring without a prescription, delivering medical-grade performance directly to consumers while allowing wireless connectivity to compatible apps for tracking, sharing, and storing readings. In contrast, a prescription (Medical) version of a wearable or fingertip pulse oximeter would be intended for clinical use under the guidance of healthcare professionals in medical environments such as hospitals, clinics, or long-term care settings, with specifications, calibration, and regulatory compliance tailored to support clinical decision-making and diagnosis, whereas the OTC version focuses on reliable self-monitoring and daily health tracking for non-clinical use.
3) Masimo
Masimo is a technology-driven medical devices and digital health company whose business centers on the development of noninvasive monitoring solutions, patient-care connectivity platforms, and integrated clinical intelligence systems used across hospital, home-care, emergency, and remote-monitoring environments. The company focuses on combining advanced signal processing, sensor innovation, and software analytics to improve the reliability and usability of physiological monitoring in real-world conditions, particularly in situations involving motion, low perfusion, and diverse patient populations. Through close collaboration with clinicians, health-system partners, and device manufacturers, Masimo positions its technologies as foundational components within broader care-delivery ecosystems, supporting both standalone devices and networked monitoring architectures, data exchange with hospital information systems, and digital tools that enable care teams to make more informed and timely decisions.
Within its pulse oximetry portfolio, Masimo designs and manufactures a range of wearable, fingertip, handheld, and bedside pulse oximeters built on its proprietary Signal Extraction Technology (SET®) and related algorithms, which are engineered to provide stable and accurate measurements of oxygen saturation (SpO₂), pulse rate, perfusion index, and related parameters across challenging clinical and daily-use conditions. The company’s pulse oximeters emphasize ergonomic sensor design, intuitive user interfaces, and clear physiological displays, while selected models incorporate wireless connectivity and data-trending capabilities to support remote monitoring workflows and extended health-management use cases. Masimo offers devices that span Over-the-counter Pulse Oximeters for personal and home-use self-monitoring, as well as prescription-grade and clinically focused pulse oximeters intended for professional medical environments, creating a product landscape that bridges consumer wellness applications with advanced monitoring requirements in acute and chronic care settings.
The Masimo MightySat Rx is an FDA-cleared Wearable Pulse Oximeter combining advanced, clinically proven Masimo Signal Extraction Technology® (SET®) with an intuitive fingertip form factor and touchscreen display to deliver fast, reliable, non-invasive spot-check monitoring of key physiological parameters including arterial oxygen saturation (SpO₂), pulse rate (PR), perfusion index (Pi), and optionally pleth variability index (PVi®) and respiration rate from the pleth (RRp®), with results presented clearly within seconds on an easy-to-read OLED interface and, on selected models, wirelessly transmitted via Bluetooth to compatible mobile apps for trend tracking and data sharing. Designed to provide accurate measurements through motion and low perfusion conditions using the same technology widely used in leading hospitals, the device offers both over-the-counter availability under FDA clearance for direct consumer use without a prescription, enabling individuals to perform daily SpO₂ and pulse monitoring at home or on the go with medical-grade performance, and in contrast a prescription (medical) version of a pulse oximeter would be intended for clinical use under healthcare professional supervision in settings such as hospitals, clinics, or long-term care environments with specifications, calibration, and regulatory compliance tailored for diagnostic and clinical decision-making support, whereas the OTC MightySat Rx focuses on accessible, reliable self-monitoring for general health and wellness needs.
4) Viatom Technology
Viatom Technology is a medical-technology company focused on the development and manufacturing of noninvasive health-monitoring devices and intelligent digital-health solutions, with its business centered on wearable physiological monitoring, signal-acquisition hardware, and companion software platforms that support long-term personal and remote health-management scenarios across home-care, wellness, sleep-monitoring, and tele-health environments. The company emphasizes compact device engineering, ergonomic industrial design, and integrated data-analytics capabilities that enable continuous and user-friendly physiological tracking in everyday settings, while also prioritizing regulatory compliance, reliability verification, and interoperability with mobile applications and cloud-based data platforms to support extended monitoring, user engagement, and clinician-supported review workflows when applicable.
Within its pulse oximetry portfolio, Viatom Technology designs and produces a range of wearable, wrist-based, and fingertip pulse oximeters that combine optical sensing technology with proprietary algorithms to provide stable measurements of oxygen saturation (SpO₂), pulse rate, and related indicators during daily activity and sleep-monitoring conditions, including low-motion and nighttime environments. The company’s devices typically feature lightweight wearable form factors, ring- or fingertip-style sensors, vibration or threshold-based alert functions, and Bluetooth connectivity to companion applications for trend visualization, data recording, and long-term health tracking. Viatom Technology offers products that span Over-the-counter Pulse Oximeters intended for personal self-monitoring and consumer health use, as well as models aligned with clinical or prescription-guided monitoring needs, forming a product landscape that links consumer wellness monitoring with extended observation and professional-supported use cases in broader digital-health and remote-monitoring ecosystems.
The Viatom Checkme O2 wrist pulse oximeter is an FDA-cleared Wearable Pulse Oximeter designed to continuously and non-invasively monitor blood oxygen saturation (SpO₂), pulse rate, and motion throughout the day or night using a comfortable, user-friendly wrist-worn form factor with a patented ring sensor that remains secure without constricting the finger, and provides vibration alerts when blood oxygen levels drop below preset thresholds to help users maintain awareness of potential hypoxia events such as those associated with sleep-disordered breathing. Certified by the U.S. Food and Drug Administration and CE, the Checkme O2 supports extended monitoring sessions of up to approximately 10 hours and pairs with companion applications via Bluetooth for real-time data tracking and recording, displaying oxygen saturation and pulse metrics on an OLED screen while offering adjustable alert settings for individualized use. As an over-the-counter pulse oximeter, this model is cleared for direct consumer use without a prescription for general health and wellness monitoring, sleep tracking, and daily SpO₂/pulse rate assessment at home; in contrast, a prescription (medical) version of a wearable or wrist pulse oximeter would be intended for clinical environments such as hospitals, clinics, or long-term care settings under healthcare professional guidance, with regulatory compliance, calibration, and functional specifications tailored to support medical decision-making and diagnostic purposes, whereas the OTC Checkme O2 emphasizes accessible, reliable self-monitoring for non-clinical long-term observation and personal health awareness.
3. Key Market Trends, Opportunity, Drivers and Restraints
1) Market Trends
The development of the FDA-cleared Wearable Pulse Oximeter is showing an increasing trend toward stricter regulatory requirements, accelerated technological integration, and the expansion of application scenarios into medical-grade use. In January 2025, the FDA released a new draft guideline aimed at addressing accuracy discrepancies in devices for different skin tones. The new guideline suggests significantly increasing the clinical research sample size, requiring the test population to include a wide range of skin tones, with at least 25% of participants from darker skin tones. This move marks a rapid transition of the pulse oximeter industry from “usable” to “fair and reliable” medical-grade standards. At the same time, technological innovation is driving product diversification, with traditional fingertip clip designs merging with wearable devices like smartwatches, rings, and patches. Artificial intelligence and multi-wavelength optoelectronics are becoming the frontier of research, helping overcome interference from skin tone variations and motion artifacts, improving measurement accuracy and robustness. With continuous technological advancements, the application scenarios for FDA-cleared Wearable Pulse Oximeters are expanding into medical-grade devices. The market is now presenting a bifurcation: one side consists of consumer-level health devices that do not require approval, while the other side comprises prescription-grade medical devices that require FDA 510(k) approval. The latter can be integrated into remote patient monitoring platforms, and their clinical data can be used to guide treatments, with clear reimbursement codes (such as the U.S. CPT code) accelerating their adoption in the healthcare system.
5) Opportunities
The future development opportunities for FDA-cleared Wearable Pulse Oximeters are primarily reflected in the management of chronic diseases, the fulfillment of health equity demands, and penetration into emerging markets. With the ongoing growth of cardiovascular diseases, chronic obstructive pulmonary disease (COPD), and other chronic conditions, the demand for continuous home monitoring is increasing. FDA-cleared Wearable Pulse Oximeters can provide long-term, real-time monitoring of vital signs, helping with early warning and supporting chronic disease management, thus aligning with the global healthcare system’s reform direction of “shifting care to earlier stages and reducing costs.” Furthermore, current devices face performance gaps in certain groups, such as those with darker skin tones, children, and critically ill patients, creating a clear clinical need. Wearable pulse oximeters that undergo rigorous diversity testing and demonstrate cross-population applicability not only meet regulatory requirements but also seize a massive differentiated market opportunity, advancing health equity. Meanwhile, with the improvement of medical infrastructure and growing health awareness in emerging markets like Asia-Pacific, the market for home-use and wearable medical devices is expanding rapidly. In these regions, cost-effective and easy-to-use FDA-cleared Wearable Pulse Oximeters are expected to gain widespread adoption, further expanding global market share.
6) Challenges
The development of FDA-cleared Wearable Pulse Oximeters faces a series of challenges and obstacles. First, improving accuracy across different skin tones involves complex technological issues, including optical design, algorithm compensation, and clinical validation. This process is not only technically difficult but also requires lengthy and costly clinical trials to meet the new regulatory guidelines, significantly increasing development costs and time. Second, regulatory and legal risks are also increasing. While the FDA’s new guidelines are not mandatory, they reflect the expectations of regulatory authorities, and non-compliance may lead to products being unable to obtain approval. Moreover, inaccurate device data has already triggered several lawsuits (such as class actions against Apple and Medtronic), posing significant reputational and financial risks to manufacturers. Third, the issue of data quality and integration is also a major challenge. The quality of wearable device data is inconsistent, and there is a lack of standardized protocols, making it difficult to integrate the data with medical institutions’ electronic health records, hindering its widespread adoption in clinical decision-making. Finally, there are still barriers in market education and payment. Both doctors and patients need to develop more trust in wearable medical data, and the establishment of clear insurance reimbursement processes and acceptance by payers is critical for large-scale commercialization of the product. Currently, this system is still under development.
7) Industry Entry Barriers
The entry barriers to the FDA-cleared Wearable Pulse Oximeter industry are high, primarily due to regulatory access, technology and patent protection, clinical evidence, and market channels. First, obtaining FDA 510(k) or De Novo approval requires strict design control, biocompatibility testing, software verification, and clinical trials. This process typically takes several years and requires a significant financial investment, posing a substantial time and financial barrier for new entrants. Second, the core optical sensing technology, interference-resistant algorithms, and multi-wavelength and AI-driven technologies developed to meet new standards are often tightly protected by patents held by leading companies, making it difficult for later entrants to bypass these technology barriers. Additionally, establishing clinical credibility and gaining widespread market recognition requires collaboration with top academic institutions, publishing high-level research papers, and conducting large-scale, multi-center clinical trials. Building these academic and clinical networks is not an overnight process. Finally, market and channel barriers are also significant. The medical device market relies on established distributor networks and direct partnerships with large hospitals and healthcare systems, giving established companies with brand reputation and sales channels (such as Medtronic, Masimo, and Philips) a clear competitive advantage. Consumer electronics giants, such as Apple, are also entering the market with their large user ecosystem and brand influence, intensifying competition.
4. Supply Chain Analysis
1) Upstream Market
a) Sensors and Optical Components — Red/Infrared LED Emitters, Photodetectors (Photodiodes), Flexible Optoelectric Sensors
Sensors and optical components serve as critical upstream raw materials and have a direct and decisive impact on the performance, accuracy, and user experience of the final device. The red/infrared LED emitter is the core light-source component of a pulse oximeter, emitting light at specific wavelengths—typically using dual-wavelength LEDs at approximately 660 nm (red) and 940 nm (near-infrared). These light waves penetrate the skin and blood tissues, where differences in absorption characteristics enable the acquisition of oxygen saturation (SpO₂) and pulse information in pulsatile blood flow. The wavelength precision, optical power stability, and spectral consistency of the LED emitter directly affect the ability of optical signals to effectively penetrate tissue and be returned for detection; controlling these parameters is essential for ensuring measurement accuracy. High-quality LED emitters can reduce wavelength drift and output fluctuation during emission, thereby improving the reliability of oxygen-saturation measurements. The photodetector (photodiode) functions as the signal-capture component, converting reflected or transmitted light signals from human tissue into electrical signals and serving as a core detection unit for SpO₂ measurement. High-sensitivity and low-noise photodiodes are able to accurately capture subtle variations in reflected light under low-light conditions, helping to enhance monitoring precision and resistance to interference. Photodiodes commonly adopt a PIN structure to improve response speed and are used together with optical filters and electronic amplification circuits to optimize signal extraction in response to challenges caused by variations in skin, tissue, and ambient light. Flexible optoelectric sensors represent an innovative class of optical components in the development of wearable pulse oximeters. Manufactured on flexible substrates (such as thermoplastic polyurethane TPU films), these sensors conform more closely to the skin surface, improving wearing comfort and stability during long-term monitoring. Compared with optical components mounted on traditional rigid circuit boards, flexible optoelectric sensors can better adapt to curved body surfaces, reduce motion artifacts, and significantly improve data quality in continuous-monitoring and sleep-monitoring scenarios, while also supporting thinner device structures and ergonomic design. Because the performance of these optical components directly determines the accuracy and consistency of cardiovascular and oxygen-saturation measurements, high-performance red/infrared LED emitters, high-sensitivity photodiodes, and advanced flexible optoelectric sensors are indispensable foundational components in the R&D and manufacturing of FDA-cleared Wearable Pulse Oximeters, ensuring that devices meet medical-grade monitoring standards.
b) Chips and Electronic Components — Dedicated SpO₂ Measurement Chips, Main-Control MCU, Bluetooth Modules
Chips and electronic components are the core upstream raw materials enabling high-performance monitoring, reliable data computation, and real-time communication, and they play a key role in determining whether a device can achieve medical-grade accuracy and usability. The dedicated SpO₂ measurement chip typically integrates LED driving, photodetection, and preliminary signal-processing functions into a single chip. It both drives light sources of specific wavelengths to emit optical signals toward the skin and receives reflected or transmitted signals captured by optical elements for initial filtering and preprocessing. This highly integrated design greatly simplifies peripheral circuitry, enabling a higher degree of miniaturization and low-power operation, while also providing clean and stable raw data for subsequent complex algorithm computation. The main-control MCU (microcontroller unit) is responsible for overall system management: it runs oxygen-saturation and signal-analysis algorithms, schedules hardware resources, controls peripheral modules, and manages communication processes. In wearable pulse oximeters, achieving a balance between low power consumption and computing performance is the core design requirement of the MCU. A well-selected MCU ensures stable execution of computation and control tasks during continuous monitoring, without excessive power consumption that would rapidly drain the battery—an essential condition for devices intended for all-day wear. The Bluetooth module, especially low-energy Bluetooth (BLE), has become a standard communication component in FDA-cleared Wearable Pulse Oximeters. It enables data transmission between the device and smartphones or cloud platforms, allowing measurement results to be displayed, stored, and shared in companion applications in real time, while also supporting trend analysis and remote-monitoring functions. The adoption of low-energy Bluetooth not only extends battery life while maintaining reliable wireless transmission, but also provides standardized interoperability within the mobile-health ecosystem, which is important for long-term self-monitoring and clinical review. Overall, the coordinated optimization of these chips and electronic components promotes the miniaturization, intelligence, and connectivity of wearable pulse oximeters, while providing a solid technical foundation for devices to meet FDA requirements related to accuracy, stability, and data integrity.
c) Flexible Materials and Structural Components — Flexible Substrates, Encapsulation Materials
Flexible materials and structural components are key upstream raw materials that enable long-term reliable wear, enhance user comfort, and ensure monitoring stability, and they have a direct impact on device performance and user experience. Flexible substrates are commonly used as the base material for printed circuits and as skin-contact liner layers. Such materials must offer good flexibility, tear resistance, and biocompatibility suitable for long-term skin contact, allowing the oxygen-measurement sensor to better conform to curved body surfaces, thereby reducing errors caused by motion or prolonged wear while significantly improving comfort and adaptability. The selection of flexible substrates must also consider durability and stability under different temperature and humidity conditions to ensure reliable mechanical and electrical performance during continuous monitoring of physiological indicators such as oxygen saturation and pulse rate. Encapsulation materials are used in the outer housing, adhesive patches, or skin-contact regions of wearable pulse oximeters and serve primarily to protect internal electronic components and sensors, while also ensuring skin-contact safety, breathability, and resistance to sweat and skin oils. High-quality encapsulation materials prevent sweat and oils from entering the interior of the device during daily use and, through breathable design, help reduce skin irritation and discomfort, thereby supporting the reliability of FDA-cleared Wearable Pulse Oximeters in long-duration clinical and home-monitoring scenarios. The optimization of flexible materials and structural components not only enhances comfort and wearing convenience, but also provides a foundation for continuous, high-quality physiological data acquisition, making them core foundational elements driving the miniaturization, comfort, and high adaptability of wearable pulse oximeters.
d) Lithium Batteries and Protection ICs
Lithium batteries and protection ICs are essential upstream raw materials that ensure stable power supply, safe operation, and user experience, and they have a direct impact on device endurance, reliability, and overall performance. The lithium battery is the primary energy source of a wearable pulse oximeter. Its high energy density, small size, and light weight enable round-the-clock or multi-night continuous monitoring while maintaining a lightweight and comfortable wearing experience. High-quality lithium batteries must also meet medical-grade safety and reliability requirements to ensure that long-term use does not result in risks such as thermal runaway or leakage due to improper charging or discharging. Battery performance is directly linked to device operating time and user confidence in the monitoring experience, and long battery life is particularly important in scenarios such as sleep monitoring, chronic-disease management, and remote healthcare, where it improves user adherence and clinical usability. The protection IC (such as DW01+ and similar devices) serves as the core of the battery-power-management system, monitoring battery charging and discharging states and implementing protection mechanisms to prevent overcharging, over-discharging, overcurrent, or short-circuit events, thereby ensuring the safety of the battery pack and the entire device circuitry. Such protection circuits not only help extend battery life, but also safeguard sensitive internal electronic components under extreme power conditions, reducing risks of data loss or measurement errors caused by power anomalies, and supporting the stable operation of FDA-cleared Wearable Pulse Oximeters in continuous-monitoring and high-reliability application scenarios. In summary, lithium batteries and protection ICs constitute the core of the power-supply system, not only providing essential energy support for the device, but also, through safety protection and power-management functions, delivering important technical assurance for reliability, durability, and user experience in both medical and home-monitoring contexts for wearable pulse oximeters.
8) Midstream
a) Over-the-counter Pulse Oximeter
An over-the-counter pulse oximeter generally refers to a wearable pulse oximeter that has obtained FDA medical-device clearance and is explicitly labeled in its indications for use as suitable for “Over-the-Counter” use, meaning it may be sold directly to consumers without a prescription while still retaining the regulatory attributes of a medical device, as opposed to consumer electronics features marketed only for “health and fitness” purposes that have not undergone FDA performance review. In its safety communications, the FDA has specifically stated that it does not evaluate the accuracy of general wellness–type pulse oximeters, while also reminding the public that both over-the-counter and prescription pulse oximeters have limitations and may produce affected readings under conditions such as poor circulation or darker skin pigmentation. Therefore, a true FDA-cleared wearable OTC pulse oximeter must demonstrate safety and performance under defined conditions through pathways such as 510(k) before being authorized for market entry. In terms of product form factor, representative companies such as Masimo and Nonin have introduced FDA-approved OTC fingertip or wearable pulse oximeters that emphasize the use of pulse-oximetry technologies derived from or consistent with those applied in hospital settings, and support visualization, trend review, and data-sharing functions through companion mobile applications, providing adult users with self-monitoring tools in home care, daily activity, and home-recovery scenarios. From an industry-development perspective, the FDA has continued, through its 2021 safety communication and subsequent guidance efforts, to highlight accuracy concerns across different skin-tone populations, while more recent draft guidance proposes more detailed performance and labeling recommendations for pulse oximeters intended for medical purposes. Together, these actions form a clearer compliance pathway, enabling standard-compliant OTC wearable pulse oximeters to be more effectively deployed in home monitoring and remote-health-management contexts under a medical-grade quality framework, while consumer accessibility may be further enhanced through the use of health-related spending and reimbursement tools permitted under applicable policies.
b) Prescription Pulse Oximeter
Within the context of FDA-cleared Wearable Pulse Oximeters, a prescription pulse oximeter refers to a wearable oxygen-monitoring device that is labeled “Rx only” and must be used under the supervision of qualified healthcare professionals or within an established clinical-care environment. Such devices are typically cleared through the 510(k) or De Novo regulatory pathway, with their primary indications for use defined as noninvasive monitoring of blood oxygen saturation and pulse rate “for medical purposes,” and the data generated by these products may be incorporated into clinical evaluation, diagnostic decision-making, and remote-patient-monitoring programs. These devices commonly appear in the form of wrist-watch or wrist-band wearables, adhesive patches, or fingertip modules that can operate in conjunction with bedside monitoring systems in inpatient or perioperative settings, while also supporting wireless integration into remote vital-sign monitoring platforms and being used as part of home-based follow-up for chronic and acute conditions. Relevant payment and policy frameworks in the United States have included oxygen saturation and pulse rate among the vital signs eligible for remote physiologic monitoring services, providing clear reimbursement codes and compliance foundations for the deployment of such prescription wearable devices within clinical workflows. From a technology and regulatory-trend perspective, the FDA, through its safety communications and a draft document released in 2025, has focused on performance differences in prescription pulse oximeters under conditions such as darker skin pigmentation, low perfusion, and ambient-light interference, and has proposed more representative clinical-evaluation and labeling recommendations. These developments are encouraging manufacturers to enhance product design around multi-skin-tone performance equity and clinical interpretability, positioning companies with sustained R&D capabilities and strong clinical-collaboration networks more favorably in the next cycle of product iteration and expansion of remote-monitoring applications.
9) Downstream
a) Medical Decision Making
FDA-cleared Wearable Pulse Oximeters perform the non-invasive monitoring of key vital signs such as blood oxygen saturation and pulse rate, and the data generated by these devices are used to support clinical judgment, diagnostic processes, and treatment management. According to the U.S. Food and Drug Administration, pulse oximetry devices estimate the oxygen saturation level in the blood and provide pulse-rate information through optical signal measurement, offering clinicians a rapid and noninvasive physiological reference indicator that helps identify pathological conditions such as the risk of hypoxemia and prompts clinicians to take appropriate action before medical intervention becomes necessary. The FDA’s draft guidance for such devices also emphasizes the importance of accuracy across populations with different levels of skin pigmentation and the need for clinical performance validation, with these regulatory measures intended to improve reliability and consistency when the devices are used for medical purposes. In practical clinical settings, FDA-cleared Wearable Pulse Oximeters can be integrated with bedside monitoring systems, remote patient-monitoring platforms, or electronic health-record systems to support condition assessment, ward management, and follow-up decision making for patients with acute and chronic diseases, while accurate device labeling and performance information help healthcare professionals understand device limitations and appropriate use conditions, thereby enhancing safety in Medical Decision Making.
b) Daily Monitoring
FDA-cleared Wearable Pulse Oximeters are designed for continuous or periodic vital-sign monitoring in personal or home environments, providing non-professional users with a reliable tool to track changes in their blood oxygen saturation and pulse rate. In its patient and consumer guidance, the FDA clearly states that pulse oximeters may be used to estimate blood oxygen levels non-invasively, without the need for blood sampling, enabling users to understand their physiological status in home-care, rehabilitation-tracking, or everyday health-management scenarios. Unlike general wellness or fitness devices that are not subject to medical-device regulation, FDA-cleared wearable pulse oximeters must undergo performance evaluation to demonstrate safety and effectiveness under defined operating conditions, which gives them a higher level of credibility for Daily Monitoring use cases such as sleep tracking, chronic-disease self-management, and remote health observation. In addition, the FDA’s draft guidance recommends larger and more comprehensive test designs to ensure accuracy across a range of skin-pigmentation levels, which helps improve the performance of such devices in diverse user populations during daily monitoring. Overall, FDA-cleared Wearable Pulse Oximeters not only provide individuals with information about their own health status in Daily Monitoring contexts, but also offer more reliable data sources for healthcare teams when remote assessment based on home-collected data is required.
The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.
The FDA-cleared Wearable Pulse Oximeter market is segmented as below:
By Company
Nonin Medical
Zacurate
Viatom Technology
OxiWear
Masimo
Movano Health
BodiMetrics
Medtronic
MightySat Medical
Guangdong Transtek Medical Electronics
Jiangsu Yuyue Medical Equipment and Supply
Contec Medical Systems
Beijing Lepu Medical
Hunan Cofoe Medical Technology
Segment by Type
Over-the-counter Pulse Oximeter
Prescription Pulse Oximeter
Segment by Application
Medical Decision Making
Daily Monitoring
Others
Each chapter of the report provides detailed information for readers to further understand the FDA-cleared Wearable Pulse Oximeter market:
Chapter 1: Introduces the report scope of the FDA-cleared Wearable Pulse Oximeter report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. (2021-2032)
Chapter 2: Detailed analysis of FDA-cleared Wearable Pulse Oximeter manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. (2021-2026)
Chapter 3: Provides the analysis of various FDA-cleared Wearable Pulse Oximeter market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. (2021-2032)
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.(2021-2032)
Chapter 5: Sales, revenue of FDA-cleared Wearable Pulse Oximeter in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world..(2021-2032)
Chapter 6: Sales, revenue of FDA-cleared Wearable Pulse Oximeter in country level. It provides sigmate data by Type, and by Application for each country/region.(2021-2032)
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. (2021-2026)
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Benefits of purchasing QYResearch report:
Competitive Analysis: QYResearch provides in-depth FDA-cleared Wearable Pulse Oximeter competitive analysis, including information on key company profiles, new entrants, acquisitions, mergers, large market shear, opportunities, and challenges. These analyses provide clients with a comprehensive understanding of market conditions and competitive dynamics, enabling them to develop effective market strategies and maintain their competitive edge.
Industry Analysis: QYResearch provides FDA-cleared Wearable Pulse Oximeter comprehensive industry data and trend analysis, including raw material analysis, market application analysis, product type analysis, market demand analysis, market supply analysis, downstream market analysis, and supply chain analysis.
and trend analysis. These analyses help clients understand the direction of industry development and make informed business decisions.
Market Size: QYResearch provides FDA-cleared Wearable Pulse Oximeter market size analysis, including capacity, production, sales, production value, price, cost, and profit analysis. This data helps clients understand market size and development potential, and is an important reference for business development.
Other relevant reports of QYResearch:
Global FDA-cleared Wearable Pulse Oximeter Market Outlook, In‑Depth Analysis & Forecast to 2032
Global FDA-cleared Wearable Pulse Oximeter Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Global FDA-cleared Wearable Pulse Oximeter Market Research Report 2026
About Us：
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 19 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
